AAAAAA
Results: 1-25/251
Authors:
Crowe, SM
Mills, J
Mijch, A
Citation: Sm. Crowe et al., Overview of the Australasian Society for HIV Medicine 12th Annual conference - Preface, J CLIN VIRO, 22(3), 2001, pp. 215-216
Authors:
Campbell, SM
Crowe, SM
Mak, J
Citation: Sm. Campbell et al., Lipid rafts and HIV-1: from viral entry to assembly of progeny virions, J CLIN VIRO, 22(3), 2001, pp. 217-227
Authors:
Turville, SG
Cameron, PU
Arthos, J
MacDonald, K
Clark, G
Hart, D
Cunningham, AL
Citation: Sg. Turville et al., Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection, J CLIN VIRO, 22(3), 2001, pp. 229-239
Authors:
Gahan, ME
Miller, F
Lewin, SR
Cherry, CL
Hoy, JF
Mijch, A
Rosenfeldt, F
Wesselingh, SL
Citation: Me. Gahan et al., Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction, J CLIN VIRO, 22(3), 2001, pp. 241-247
Authors:
Pemberton, LA
Brew, BJ
Citation: La. Pemberton et Bj. Brew, Cerebrospinal fluid S-100 beta and its relationship with AIDS dementia complex, J CLIN VIRO, 22(3), 2001, pp. 249-253
Authors:
Pierce, AB
Hoy, JF
Citation: Ab. Pierce et Jf. Hoy, Is the recommendation for pneumococcal vaccination of HIV patients evidence based?, J CLIN VIRO, 22(3), 2001, pp. 255-261
Authors:
Birch, MR
Learmont, JC
Dyer, WB
Deacon, NJ
Zaunders, JJ
Saksena, N
Cunningham, AL
Mills, J
Sullivan, JS
Citation: Mr. Birch et al., An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC), J CLIN VIRO, 22(3), 2001, pp. 263-270
Authors:
Mijch, AM
Hoy, J
Watson, K
Dunne, A
Crowe, S
Wesselingh, SL
Citation: Am. Mijch et al., Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?, J CLIN VIRO, 22(3), 2001, pp. 271-278
Authors:
Price, P
Mathiot, N
Krueger, R
Stone, S
Keane, NM
French, MA
Citation: P. Price et al., Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy, J CLIN VIRO, 22(3), 2001, pp. 279-287
Authors:
Pett, SL
Emery, S
Citation: Sl. Pett et S. Emery, Immunomodulators as adjunctive therapy for HIV-1 infection, J CLIN VIRO, 22(3), 2001, pp. 289-295
Authors:
McDonald, A
Donovan, B
O'Connor, C
Packham, D
Patten, J
Chuah, J
Waddell, R
Fairley, CK
Kaldor, J
Citation: A. Mcdonald et al., Time trends in HIV incidence among homosexually active men seen at sexual health clinics in Australia, 1993-1999, J CLIN VIRO, 22(3), 2001, pp. 297-303
Authors:
Russell, DB
Tabrizi, SN
Russell, JM
Garland, SM
Citation: Db. Russell et al., Seroprevalence of herpes simplex virus types 1 and 2 in HIV-Infected and uninfected homosexual men in a primary care setting, J CLIN VIRO, 22(3), 2001, pp. 305-313
Authors:
Holmes, W
Kwarteng, T
Citation: W. Holmes et T. Kwarteng, Parent to child transmission of HIV: policy considerations in the Asia-Pacific region, J CLIN VIRO, 22(3), 2001, pp. 315-324
Authors:
Biel, SS
Madeley, D
Citation: Ss. Biel et D. Madeley, Diagnostic virology - the need for electron microscopy: a discussion paper, J CLIN VIRO, 22(1), 2001, pp. 1-9
Authors:
Arens, M
Citation: M. Arens, Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV, J CLIN VIRO, 22(1), 2001, pp. 11-29
Authors:
Llames, L
Goyache, J
Domenech, A
Arjona, A
Suarez, G
Gomez-Lucia, E
Citation: L. Llames et al., Evaluation of virus excretion by cells persistently infected with the bovine leukaemia virus (BLV) using monoclonal antibodies, J CLIN VIRO, 22(1), 2001, pp. 31-39
Authors:
Kannangai, R
Ramalingam, S
Prakash, KJ
Abraham, OC
George, R
Castillo, RC
Schwartz, DH
Jesudason, MV
Sridharan, G
Citation: R. Kannangai et al., A peptide enzyme linked immunosorbent assay (ELISA) for the detection of human immunodeficiency virus type-2 (HIV-2) antibodies: an evaluation on polymerase chain reaction (PCR) confirmed samples, J CLIN VIRO, 22(1), 2001, pp. 41-46
Authors:
Nedeljkovic, J
Jovanovic, T
Oker-Blom, C
Citation: J. Nedeljkovic et al., Maturation of IgG avidity to individual rubella virus structural proteins, J CLIN VIRO, 22(1), 2001, pp. 47-54
Authors:
Ennis, O
Corcoran, A
Kavanagh, K
Mahon, BP
Doyle, S
Citation: O. Ennis et al., Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirmingrecent infection, J CLIN VIRO, 22(1), 2001, pp. 55-60
Authors:
Schinkel, J
Kroes, ACM
Wagtmans, MJ
Lamers, CBHW
van Hoek, B
Citation: J. Schinkel et al., Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays, J CLIN VIRO, 22(1), 2001, pp. 61-71
Authors:
De Clercq, E
Citation: E. De Clercq, Antiviral drugs: current state of the art, J CLIN VIRO, 22(1), 2001, pp. 73-89
Authors:
Biagini, P
Gallian, P
Attoui, H
Cantaloube, JF
Touinssi, M
de Micco, P
de Lamballerie, X
Citation: P. Biagini et al., Comparison of systems performance for TT virus detection using PCR primer sets located in non-coding and coding regions of the viral genome, J CLIN VIRO, 22(1), 2001, pp. 91-99
Authors:
Barenfanger, J
Drake, C
Mueller, T
Troutt, T
O'Brien, J
Guttman, K
Citation: J. Barenfanger et al., R-Mix cells are faster, at least as sensitive and marginally more costly than conventional cell lines for the detection of respiratory viruses, J CLIN VIRO, 22(1), 2001, pp. 101-110
Authors:
Piiparinen, H
Hockerstedt, K
Gronhagen-Riska, C
Lappalainen, M
Suni, J
Lautenschlager, I
Citation: H. Piiparinen et al., Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients, J CLIN VIRO, 22(1), 2001, pp. 111-116
Authors:
Lehtinen, M
Luukkaala, T
Wallin, KL
Paavonen, J
Thoresen, S
Dillner, J
Hakama, M
Citation: M. Lehtinen et al., Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction, J CLIN VIRO, 22(1), 2001, pp. 117-124